Alemtuzumab and erysipeloid Patient Reports February 13, 2012

Alemtuzumab Side Effects Report #5782664-3
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Male patient, 47 years of age, was diagnosed with immunosuppression, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: erysipeloid, neutropenia, pneumonia fungal, renal failure, urinary tract infection , zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with RITUXIMAB, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, CASPOFUNGIN, AMPHOTERICIN B. Patient recovered.

Alemtuzumab Side Effects Report #5787439-7
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on June 09, 2008. Male patient, 47 years of age, was diagnosed with immunosuppression, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: erysipeloid, neutropenia, pneumonia fungal, renal failure, urinary tract infection , zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with RITUXIMAB, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, CASPOFUNGIN, AMPHOTERICIN B. Patient recovered.

Alemtuzumab Side Effects Report #5795840-0
Alemtuzumab side effect was reported by a Health Professional from UNITED STATES on June 16, 2008. Male patient, 47 years of age, was diagnosed with immunosuppression, antifungal prophylaxis and was treated with Alemtuzumab. After drug was administered, patient experienced the following side effects: erysipeloid, neutropenia, pneumonia fungal, renal failure, surgical procedure repeated, transplant, transplant rejection, urinary tract infection , zygomycosis. Alemtuzumab dosage: unknown. During the same period patient was treated with RITUXIMAB, PREDNISOLONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, CASPOFUNGIN, AMPHOTERICIN B. Patient recovered.